ENDOVITE Trademark

Trademark Overview


On Sunday, September 25, 2022, a trademark application was filed for ENDOVITE with the United States Patent and Trademark Office. The USPTO has given the ENDOVITE trademark a serial number of 97606083. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, May 29, 2024. The ENDOVITE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Vi...

Vitamin therapy; Providing information to patients in the field of administering medication
endovite

General Information


Serial Number97606083
Word MarkENDOVITE
Filing DateSunday, September 25, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, May 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements


Goods and ServicesPharmaceutical agents affecting peripheral nervous system; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Vitamin supplements; Vitamin tablets; Vitamins; Anti-diabetic pharmaceuticals; Cardiovascular pharmaceuticals; Multi-vitamin preparations; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; none of the foregoing in connection with prescription pharmaceutical preparations
Goods and ServicesVitamin therapy; Providing information to patients in the field of administering medication

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 12, 2022
Primary Code005
First Use Anywhere DateMonday, December 18, 2023
First Use In Commerce DateMonday, December 18, 2023

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 12, 2022
Primary Code044
First Use Anywhere DateMonday, December 18, 2023
First Use In Commerce DateMonday, December 18, 2023

Trademark Owner History


Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressDuluth, GA 30097

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressDuluth, GA 30097

Trademark Events


Event DateEvent Description
Wednesday, September 28, 2022NEW APPLICATION ENTERED
Wednesday, October 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 10, 2023ASSIGNED TO EXAMINER
Monday, July 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, September 6, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Saturday, September 23, 2023TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, October 24, 2023ASSIGNED TO PETITION STAFF
Wednesday, October 25, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, October 26, 2023CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Monday, December 18, 2023USE AMENDMENT FILED
Monday, December 18, 2023TEAS STATEMENT OF USE RECEIVED
Monday, January 8, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 5, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 8, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 29, 2024ASSIGNED TO EXAMINER
Wednesday, May 29, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 29, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, January 9, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 9, 2024SU - NON-FINAL ACTION - WRITTEN
Tuesday, January 9, 2024NON-FINAL ACTION E-MAILED